Xolair is the only US FDA-approved medicine to reduce allergic reactions in children and adults with one or more food allergies Basel, 2 March 2025 - Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today ...
The prevalence of allergic diseases has been increasing globally, posing significant public health challenges. Allergic reactions can range from mild, such as allergic rhinitis (AR) and conjunctivitis ...
Please provide your email address to receive an email when new articles are posted on . Participants had allergies to up to three foods. Consumption included a median of 300 mg of their allergenic ...
A clinical trial has found that the medication omalizumab, marketed as Xolair, treated multi-food allergy more effectively than oral immunotherapy (OIT) in people with allergic reactions to very small ...
Children undergoing immunotherapy for peanut allergies may achieve the same results with a lower dose. According to new research from The Hospital for Sick Children (SickKids) and Montreal Children’s ...
In a recent study published in Nature Materials, a team of researchers developed a novel oral immunotherapy platform that uses formulated inulin gel combined with food allergens to orally deliver ...
Miami, FL, Oct. 30, 2024 (GLOBE NEWSWIRE) -- Curex, the leader in telemedicine allergy immunotherapy treatments, announces the launch of its innovative at-home Sublingual Immunotherapy (SLIT) program ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results